These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1503915)

  • 1. A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
    Dixon AR; Jackson L; Chan S; Haybittle J; Blamey RW
    Br J Cancer; 1992 Aug; 66(2):402-4. PubMed ID: 1503915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
    Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
    Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.
    Stuart NS; Warwick J; Blackledge GR; Spooner D; Keen C; Taylor AR; Tyrell C; Webster DJ; Earl H
    Eur J Cancer; 1996 Oct; 32A(11):1888-92. PubMed ID: 8943670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of megestrol acetate for the treatment of advanced breast cancer.
    Sedlacek SM
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
    Ross MB; Buzdar AU; Blumenschein GR
    Cancer; 1982 Feb; 49(3):413-7. PubMed ID: 6174195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
    Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
    Allegra JC
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential hormone therapy for advanced breast cancer.
    Von Roenn JH; Bonomi PD; Gale M; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):38-43. PubMed ID: 3368799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
    Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
    Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
    Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
    Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
    Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.